USE OF INTERMEDIATE-DOSE CYTARABINE PLUS G-CSF AS PERIPHERAL BLOOD STEM CELL MOBILIZATION PROTOCOL IN 311 PATIENTS WITH ONCO-HEMATOLOGICAL DISEASES: RESULTS FROM A SINGLE INSTITUTION AF Callera; ES Rosa; F Callera;

INFLUENCE OF HYPOXIA INDUCIBLE FACTOR ALPHA (HIF-1¿) ON CELLULAR VIABILITY OF LONG-TERM CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS AF Callera; ES Rosa; F Callera;

ACUTE LEUKEMIA OF MIXED B, T AND MYELOID PHENOTYPE WITH COMPLEX KARYOTYPE: TREATABLE DISEASE OR DEATH SENTENCE? DTK Obikawa; LA Vianna; AAM Zung; ES Rosa; F Callera;